Noteworthy - Pharmaceutical Executive

ADVERTISEMENT

Noteworthy

Making Sense of the Sunshine Act

September 1, 2013

The Sunshine Act's Open Payments spending disclosure program is now live. The government's lead compliance officer explains how it will work.

Crunch TIme for Emerging Markets

September 1, 2013

Normal service will be resumed as soon as possible.

Share of Screen: Prioritizing Electronic Health Records

September 1, 2013

Are electronic health records a viable channel for engagement? Ben Comer reports.

Biopharma Innovation in Trouble?

September 1, 2013

Rising costs will mean a drop in anticipated NDAs next year, reflecting an ever-longer and more costly drug-development process that is squeezing pharma investment in R&D.

Succinctly Shire: CEO Flemming Ornskov

August 1, 2013

Shire's new CEO has a simple strategy for success: Set the pace on specialty medicines, spread the positive buzz and momentum of a growth stock, and seize the opportunity to innovate.

The Case for Content

August 1, 2013

Reaching skittish consumers through objective, storydriven information is digital marketing's hottest digit. But applying this consumer phenomenon in Big Pharma presents some unique challenges, writes Peter Houston.

Breaching the Great Wall

August 1, 2013

With a revision of China's basic drug approval law now underway, a multinational team of experts is proposing major changes to make the country a world class player in innovation.

What Happened to Outsourcing in Asia?

July 2, 2013

The enthusiasm for India and China may be diminishing, writes Eric Langer.

Pharm Exec Industry Audit Slideshow

July 2, 2013

Click here to scan the metrics—including sales growth and gross margins—that PharmExec used to assess company performance and decide on this year's industry audit winner.

ADVERTISEMENT

Click here